Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGAM1 | P18669 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.40 |
| ▸ | CASP1 | P29466 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | CASP6 | P55212 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | NQO1 | P15559 | 1/20 | 0.35 |
| ▸ | ING2 | Q9H160 | 1/20 | 0.34 |
| ▸ | CASR | P41180 | 5/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MPL | P40238 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL843141 | 0.98 | PGAM1 (0.41) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL9150239 | 0.86 | HSD17B10 (0.42) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL27639479 | 0.84 | HSD17B10 (0.48) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL31251954 | 0.84 | HSD17B10 (0.48) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL1224928 | 0.83 | PGAM1 (0.53) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL28145555 | 0.80 | PGAM1 (0.52) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL28146678 | 0.80 | PGAM1 (0.52) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL11100105 | 0.80 | CA1 (0.43) | HSD17B10CASP1ALDH1A1CASP7TDP1 | |
| SCHEMBL11356717 | 0.78 | PRMT1 (0.39) | PGAM1HSD17B10CASP1ALDH1A1CASP7 | |
| SCHEMBL6690314 | 0.76 | CA1 (0.35) | HSD17B10CASP1ALDH1A1CASP7TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2722101-B1 | REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME | LG CHEMICAL LTD (KR) | 2018-10-24 | — | — | EP | claimed |
| CN-103328080-B | Comprise the reverse osmosis membrane of super hydrophilic passivation layer and manufacture the method for this reverse osmosis membrane | LG CHEM, LTD. (KR) | 2016-01-13 | — | — | CN | claimed |
| US-8770414-B2 | Reverse osmosis membrane including ultra-hydrophilic passivation layer and method of manufacturing the same | LG CHEM, LTD. (KR) | 2014-07-08 | — | — | US | claimed |
| EP-2722101-A2 | REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME | LG Chem, Ltd. (KR) | 2014-04-23 | — | — | EP | claimed |
| US-20130284663-A1 | REVERSE OSMOSIS MEMBRANE INCLUDING ULTRA-HYDROPHILIC PASSIVATION LAYER AND METHOD OF MANUFACTURING THE SAME | LG CHEM, LTD. (KR) | 2013-10-31 | — | — | US | claimed |
| US-8142953-B2 | Hydrophilic adjuvant | LG CHEM, LTD. (KR) | 2012-03-27 | — | — | US | claimed |
| US-20100167168-A1 | Hydrophilic Adjuvant | LG CHEM, LTD. (KR) | 2010-07-01 | — | — | US | claimed |
| WO-2007069867-A1 | HYDROPHILIC ADJUVANT | LG CHEM, LTD (KR) | 2007-06-21 | — | — | WO | claimed |
| EP-2722101-B1 | REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME | LG CHEMICAL LTD (KR) | 2018-10-24 | — | — | EP | disclosed |
| CN-103328080-B | Comprise the reverse osmosis membrane of super hydrophilic passivation layer and manufacture the method for this reverse osmosis membrane | LG CHEM, LTD. (KR) | 2016-01-13 | — | — | CN | disclosed |
| US-8770414-B2 | Reverse osmosis membrane including ultra-hydrophilic passivation layer and method of manufacturing the same | LG CHEM, LTD. (KR) | 2014-07-08 | — | — | US | disclosed |
| EP-2722101-A2 | REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME | LG Chem, Ltd. (KR) | 2014-04-23 | — | — | EP | disclosed |
| US-20130284663-A1 | REVERSE OSMOSIS MEMBRANE INCLUDING ULTRA-HYDROPHILIC PASSIVATION LAYER AND METHOD OF MANUFACTURING THE SAME | LG CHEM, LTD. (KR) | 2013-10-31 | — | — | US | disclosed |
| US-8142953-B2 | Hydrophilic adjuvant | LG CHEM, LTD. (KR) | 2012-03-27 | — | — | US | disclosed |
| US-20100167168-A1 | Hydrophilic Adjuvant | LG CHEM, LTD. (KR) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100167168-A1 | Hydrophilic Adjuvant | CD44, CD74, LY96 | PGAM1 3086/4885HSD17B10 1930/4885CASP1 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.